Nature Reviews - Cardiology

FEBRUARY 17, 2025

Nature Reviews Cardiology, Published online: 18 February 2025; doi:10.1038/s41569-025-01127-0 In this Review, Lee and colleagues describe the biosignal sensing principles of wearable blood pressure sensors and discuss blood pressure estimation methods, including the use of machine learning algorithms.

Blood Pressure 64

Blood Pressure 64

DAIC

APRIL 9, 2025

tim.hodson Wed, 04/09/2025 - 14:38 April 9, 2025 Idorsia Ltd recently announced that the US Food & Drug Administration (FDA), after having released Tryvio from its REMS (Risk Evaluation and Mitigation Strategy) requirement ( announced March 17, 2025 ), has now approved the updated label for Tryvio(aprocitentan). Hypertension.

52

52

Hypertension Journal

JANUARY 14, 2025

Hypertension, Volume 82, Issue 2 , Page 161-165, February 1, 2025.

Blood Pressure 75

Blood Pressure Hypertension 75

DAIC

FEBRUARY 14, 2025

tim.hodson Fri, 02/14/2025 - 14:32 Feb. tim.hodson Fri, 02/14/2025 - 14:32 Feb. By reducing systolic blood pressure and favorably impacting intra-cardiac pressures and volumes, AVIM therapy directly affects diastolic filling and myocardial relaxation. Advanced Heart Failure Cardiologist, Duke Health on Feb.

Blood Pressure 52

Blood Pressure Heart Failure Hypertension Technology 52

DAIC

MARCH 11, 2025

tim.hodson Tue, 03/11/2025 - 11:19 Mar. 10, 2025-- Corcept Therapeutics Inc., Resistant hypertension is defined by the American Heart Association as elevated blood pressure despite the use of three or more antihypertensive medications in different classes, including a diuretic.

Hypertension 82

Hypertension Blood Pressure Public Health Cardiovascular Disease 82

Medical Xpress - Cardiology

MARCH 6, 2025

The meeting is being held in New Orleans, March 69, 2025, and offers the latest science on population-based health and wellness and implications for lifestyle.

Blood Pressure 61

Blood Pressure Circulation Research 61

Circulation

FEBRUARY 23, 2025

Circulation, Volume 151, Issue 8 , Page 518-520, February 25, 2025.

Blood Pressure 79

Blood Pressure Circulation 79

DAIC

JANUARY 8, 2025

tim.hodson Wed, 01/08/2025 - 14:11 Jan. 8, 2025 Mineralys Therapeutics, Inc., The Company anticipates initiating the trial in the first quarter of 2025. a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases, hasannounced that the U.S.

Blood Pressure 52

Blood Pressure Hypertension Kidney Disease BMI 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A119-A119, February 1, 2025. Background:The deleterious effects of intensive blood pressure (BP) lowering in patients who achieved successful reperfusion may result from high BP variability (BPV).

Blood Pressure 40

Blood Pressure Outcomes Hemorrhage Stroke 40

Hypertension Journal

JANUARY 14, 2025

Hypertension, Volume 82, Issue 2 , Page e1-e3, February 1, 2025.

Blood Pressure 40

Blood Pressure Hypertension 40

DAIC

FEBRUARY 4, 2025

tim.hodson Tue, 02/04/2025 - 17:13 Feb. 3, 2025 Today, Peripheral Artery Disease (PAD)affects 10 million Americans and is the most common cause of limb amputation outside of trauma. If you have a history of diabetes, high blood pressure, or tobacco use, you should talk to your doctor about being screened for PAD.

Peripheral Arterial Disease 52

Peripheral Arterial Disease Blood Pressure Risk Factors Diabetes 52

Hypertension Journal

NOVEMBER 25, 2024

Hypertension, Volume 82, Issue 1 , Page 149-159, January 1, 2025. BACKGROUND:Patient education is needed to perform home blood pressure measurement (HBPM) according to blood pressure (BP) guidelines.

Blood Pressure 40

Blood Pressure Education Hypertension 40

DAIC

MARCH 25, 2025

tim.hodson Tue, 03/25/2025 - 16:19 March 25, 2025 Bayer plans to present data from 13 new analyses from across the KERENDIA (finerenone) comprehensive clinical trial program at the American College of Cardiology (ACC) 74 th Annual Scientific Session & Expo 2025 , in Chicago, IL, March 29-31, 2025. Bayer Pharmaceuticals.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Kidney Disease Research 52

DAIC

NOVEMBER 8, 2024

It becomes effective January 1, 2025, and is expected to remain effective for up to three years. The Paradise uRDN system is intended as an adjunctive treatment option when lifestyle changes and medications have not adequately controlled a patient’s blood pressure.

CMS 40

CMS Ultrasound Blood Pressure Reimbursement 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP102-AWP102, February 1, 2025. Background and Purpose:2022 Intracerebral Hemorrhage (ICH) guidelines encourage treatment of blood pressure (BP) as soon as possible following identification of ICH.

Blood Pressure 40

Blood Pressure Hemorrhage Nursing Education 40

The British Journal of Cardiology

FEBRUARY 4, 2025

His blood pressure was 180/110 mmHg and heart rate was 100 bpm. He had a high blood pressure and heart rate and was initially treated with glyceryl trinitrate. If the dissection extends into the aortic arch branches, ensuring adequate cerebral perfusion during surgery is crucial to preventing stroke.

Aortic 40

Aortic Blood Pressure Chest Pain Embolism 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AHUP9-AHUP9, February 1, 2025. Background:Blood pressure (BP) management is crucial for secondary prevention of stroke and myocardial infarction (MI); however, optimal BP control remains a challenge, particularly among historically disenfranchised populations.

Myocardial Infarction 40

Myocardial Infarction Blood Pressure Strokes Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A117-A117, February 1, 2025. Introduction:Autoregulation-guided blood pressure (BP) management offers a promising alternative to targeting fixed BP thresholds after acute ischemic stroke.

Blood Pressure 40

Blood Pressure Physiology Stroke Strokes 40

Hypertension Journal

MARCH 18, 2025

Hypertension, Volume 82, Issue 4 , Page 638-639, April 1, 2025.

Blood Pressure 40

Blood Pressure Hypertension 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP214-AWP214, February 1, 2025. Introduction:NIBP monitoring is commonly used for BP measurement but only measures MAP while algorithmically assigning SBP/DBP.

Blood Pressure 40

Blood Pressure Thrombolysis Stroke Strokes 40

Stroke Journal

JANUARY 26, 2025

Stroke, Volume 56, Issue 2 , Page e100-e100, February 1, 2025.

Blood Pressure 40

Blood Pressure Hemorrhage Hospital Outcomes 40

DAIC

JUNE 28, 2024

At the 77th World Health Assembly ( WHA ) during an event co-hosted with the Ministry of Health for Uganda , AstraZeneca announced that the expanded Healthy Heart Africa program will be operational in Côte d'Ivoire, Egypt, Ethiopia, Ghana, Kenya, Nigeria, Rwanda, Senegal and Uganda by the end of 2025.

Kidney Disease 111

Kidney Disease Blood Pressure Cardiovascular Disease Hypertension 111

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP66-ATMP66, February 1, 2025. Introduction:The 2022 AHA/ASA Guidelines for Nontraumatic ICH recommend initiating blood pressure (BP) reduction within 2 hours of onset and achieving a target systolic BP of 130-150 mmHg within one hour of initiating a BP medication.

Blood Pressure 40

Blood Pressure Hemorrhage Education Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ADP17-ADP17, February 1, 2025. Introduction:Following a large vessel occlusion acute ischemic stroke (LVO-AIS), cerebral autoregulation is notably compromised, making cerebral blood flow maintenance and optimal blood pressure (BP) crucial to preserving the penumbral tissue until reperfusion.

Blood Pressure 40

Blood Pressure Stroke Strokes Circulation 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP266-ATP266, February 1, 2025. Effective blood pressure (BP) management is crucial for reducing stroke and CVD risk, yet controlled hypertension remains suboptimal especially among minority populations. Background:Stroke is the 5thleading cause of death in the U.S.

Blood Pressure 40

Blood Pressure Education Hypertension Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A85-A85, February 1, 2025. Background:Systolic blood pressure (SBP) fluctuation is linked to increased death or disability in intracerebral hemorrhage (ICH) patients.

Blood Pressure 40

Blood Pressure Hemorrhage Outcomes Stroke 40

Medical Xpress - Cardiology

JANUARY 30, 2025

A medication often used to treat high blood pressure and prevent migraines was associated with a reduction in ischemic stroke risk among women using the drug for migraine prevention, according to a preliminary study presented at the American Stroke Association's International Stroke Conference 2025, held in Los Angeles, Feb.

Strokes 45

Strokes Stroke Blood Pressure Research 45

Circulation

MARCH 9, 2025

Circulation, Volume 151, Issue 10 , Page 653-655, March 11, 2025.

Blood Pressure 45

Blood Pressure Circulation Hypertension 45

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP314-ATP314, February 1, 2025. Introduction:Blood pressure (BP) control after a stroke is crucial in lowering the risk of stroke recurrence.

Blood Pressure 40

Blood Pressure Strokes Stroke Cancer 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP62-ATMP62, February 1, 2025. Background:Elevated blood pressure (BP) is common after Intracerebral Hemorrhage (ICH) and is linked with increased morbidity and mortality, partly due to hematoma expansion.

Blood Pressure 40

Blood Pressure Hemorrhage Outcomes Stroke 40

DAIC

MARCH 10, 2025

tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.

Blood Pressure 52

Blood Pressure Aortic Medicare Hypertension 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ANS7-ANS7, February 1, 2025. Background and Purpose:Intracerebral and subarachnoid hemorrhages comprise roughly 15% of all strokes but have a higher risk of mortality and morbidity than ischemic strokes.

Hemorrhage 40

Hemorrhage Blood Pressure Strokes Stroke 40

Stroke Journal

FEBRUARY 23, 2025

Stroke, Volume 56, Issue 3 , Page 640-648, March 1, 2025. BACKGROUND:Stroke incidence is decreasing in older ages but increasing in young adults. The causal effect of body mass index on stroke was significantly stronger for EOS than for LOS (odds ratio, 1.26 versus 1.03;P=0.008).

Risk Factors 40

Risk Factors Strokes Stroke Blood Pressure 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP117-ATP117, February 1, 2025. Background:Uncontrolled high blood pressure is a risk factor for acute stroke and a predictor of poor stroke outcomes.

Blood Pressure 40

Blood Pressure Strokes Stroke Risk Factors 40

DAIC

MARCH 25, 2025

tim.hodson Tue, 03/25/2025 - 16:19 March 25, 2025 Bayer plans to present data from 13 new analyses from across t he KERENDIA (finerenone) comprehensive clinical trial program at the American College of Cardiology (ACC) 74 th Annual Scientific Session & Expo 2025 , in Chicago, IL, March 29-31, 2025. Bayer Pharmaceuticals.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP18-ATMP18, February 1, 2025. Establishing clear time targets for getting imaging, initiating blood pressure control, reversing anticoagulation, and admission to Neuro ICU led to a reduction in mortality and 30 day readmissions. 30 day readmission rate dropped to 3.23%Conclusions:Having

Hemorrhage 40

Hemorrhage Blood Pressure Outcomes ICU 40

Hypertension Journal

NOVEMBER 21, 2024

Hypertension, Volume 82, Issue 1 , Page 106-117, January 1, 2025. BACKGROUND:Neurogenic orthostatic hypotension (nOH) causes pathological falls in standing blood pressure that may or may not be symptomatic. Whether CBFv is impacted in nOH relative to related conditions without nOH and healthy controls (HC) remains unresolved.

Blood Pressure 40

Blood Pressure Hypertension Outcomes 40